Sen. John Hickenlooper (D-CO) is working on legislation related to so-called skinny labels for generic drugs, a spokesperson for the lawmaker told Inside Health Policy , days after the Supreme Court declined to take up a lower court opinion that generic drug maker Teva had said could discourage generic manufacturers from using label carve-outs to come to market and throw a wrench in Congress’ plan to increase access to generic options for patients. Details about Hickenlooper’s proposal are unavailable as...